The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 05, 2022
Filed:
Dec. 17, 2018
Applicant:
Vettore, Llc, San Francisco, CA (US);
Inventors:
Kenneth Mark Parnell, Kaysville, UT (US);
John McCall, Boca Grande, FL (US);
Donna Romero, Chesterfield, MO (US);
Assignee:
Vettore, LLC, San Francisco, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 231/14 (2006.01); C07D 231/56 (2006.01); A61P 35/00 (2006.01); C07D 207/24 (2006.01); C07C 59/01 (2006.01); C07D 205/02 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 403/10 (2006.01); C07D 403/14 (2006.01); C07D 405/04 (2006.01); C07D 405/12 (2006.01); C07D 409/04 (2006.01); C07D 413/04 (2006.01); C07D 417/04 (2006.01); C07D 213/12 (2006.01); A61K 45/06 (2006.01); A61K 31/415 (2006.01); C07D 403/06 (2006.01); C07D 405/06 (2006.01); C07D 405/14 (2006.01);
U.S. Cl.
CPC ...
C07D 231/14 (2013.01); A61K 31/415 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07C 59/01 (2013.01); C07D 205/02 (2013.01); C07D 207/24 (2013.01); C07D 213/12 (2013.01); C07D 231/56 (2013.01); C07D 401/04 (2013.01); C07D 403/04 (2013.01); C07D 403/06 (2013.01); C07D 403/10 (2013.01); C07D 403/14 (2013.01); C07D 405/04 (2013.01); C07D 405/06 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/04 (2013.01); C07D 413/04 (2013.01); C07D 417/04 (2013.01);
Abstract
Disclosed herein are compounds and compositions useful in the treatment of MCT4 mediated diseases, such as proliferative and inflammatory diseases, having the structure of Formula I: Methods of inhibition MCT4 activity in a human or animal subject are also provided.